Sponsor Pipeline

MBX Biosciences Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07699471 A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With… Hypoparathyroidism Recruiting
Phase 2
NCT06531941 Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients… Hypoparathyroidism Active, Not Recruiting
Phase 1
NCT07142707 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… Obesity Recruiting
Disease Areas
Obesity (1)
Get alerts when MBX Biosciences's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free